Growth Metrics

Sanara MedTech (SMTI) Cost of Revenue (2016 - 2025)

Sanara MedTech's Cost of Revenue history spans 15 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 16.66% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $7.5 million, down 7.6%, while the annual FY2025 figure was $7.5 million, 7.6% down from the prior year.
  • Cost of Revenue reached $1.9 million in Q4 2025 per SMTI's latest filing, roughly flat from $1.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.4 million in Q4 2022 to a low of $474433.0 in Q1 2021.
  • Average Cost of Revenue over 5 years is $1.6 million, with a median of $1.9 million recorded in 2025.
  • Peak YoY movement for Cost of Revenue: skyrocketed 330.55% in 2022, then fell 24.52% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $782772.0 in 2021, then soared by 202.66% to $2.4 million in 2022, then dropped by 24.52% to $1.8 million in 2023, then rose by 25.78% to $2.2 million in 2024, then decreased by 16.66% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Cost of Revenue are $1.9 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).